Leaflet SIMPONI 50mg / 0.5ml solution for injection in pre-filled syringe
Indicated for: autoimmune inflammatory diseases
Route of administration: injectable
Substance: golimumab (monoclonal antibody)
ATC: L04AB06 (Antineoplastic and immunomodulating agents | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Golimumab is a monoclonal antibody used for the treatment of chronic inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, and ulcerative colitis. It works by inhibiting tumor necrosis factor-alpha (TNF-alpha), a protein involved in inflammation.
The medication is administered via subcutaneous injection, usually once a month, as directed by a physician. Golimumab has shown efficacy in reducing symptoms and slowing disease progression.
Common side effects include upper respiratory tract infections, injection site reactions, and headaches. It is important for patients to be monitored for signs of infections or other complications.
Golimumab is a modern and effective option for patients with chronic inflammatory diseases, helping to improve their quality of life.
General data about SIMPONI 50mg / 0.5ml
- Substance: golimumab
- Date of latest medicines list: 01-07-2013
- Product code: W55840001
- Concentration: 50mg / 0.5ml
- Pharmaceutical form: solution for injection in pre-filled syringe
- Quantity: 1
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for golimumab
Concentrations available for golimumab
- 100mg/ml
- 50mg/0.5ml